Dorzolamide/timolol

Dorzolamide/timolol
Combination of
Dorzolamide	Carboanhydrase inhibitor
Timolol	Beta blocker
Clinical data
Trade names	Cosopt
Pregnancy category	US: C (Risk not ruled out)
Routes of administration	eye drops
ATC code	S01ED51 (WHO)
Legal status
Legal status	US: ℞-only
Identifiers
PubChem (CID)	56841571
(verify)

Dorzolamide/timolol eyedrops (trade name Cosopt) are used for lowering pressure in the eye to normal levels, and a treatment for glaucoma. The drug is a combination of two chemicals: dorzolamide hydrochloride and timolol maleate. Both chemicals work by decreasing the production of aqueous humor. It gained Food and Drug Administration (FDA) approval in April 1998, and is supplied by Merck.

External links

Drugs used for glaucoma preparations and miosis (S01E)

Sympathomimetics

Parasympathomimetics

muscarinic	Aceclidine Pilocarpine

muscarinic/nicotinic	Acetylcholine Carbachol

acetylcholinesterase inhibitors	Demecarium Ecothiopate Stigmine (Fluostigmine Neostigmine Physostigmine) Paraoxon

Carbonic anhydrase inhibitors/
(sulfonamides)

Beta blocking agents

Prostaglandin analogues (F_2α)

Other agents

This article is issued from Wikipedia - version of the 11/19/2014. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.